Concept Medical Unveils Landmark SirPAD Trial at ACC 2026, Advancing PAD Treatment
Concept Medical Inc. (CMI), a global leader in drug-delivery technologies for vascular interventions, has announced the presentation of the world’s largest randomized controlled trial evaluating a sirolimus-coated balloon (SCB) for peripheral artery disease (PAD) at the ACC 2026 Scientific Sessions.
Concept Medical | 01/04/2026 | By Darshana | 149
ANVISA Approves Concept Medical's MagicTouch SCB for CAD in Brazil
The approval enables commercial sales in Brazil, strengthening Concept Medical’s global footprint and advancing its mission to deliver safer and more effective treatment alternatives. The company is also undergoing ANVISA’s approval process for its wider DCB and DES portfolio, building on its robust clinical trial foundation.
Concept Medical | 16/09/2025 | By Dineshwori | 336
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy